{
    "code": "02021714",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021714",
    "time": "2015-08-23 11:18:39",
    "許可證字號": "衛署藥輸字第021714號",
    "註銷狀態": "已註銷",
    "註銷日期": "103\/04\/28",
    "註銷理由": "未展延而逾期者",
    "有效日期": "98\/06\/02",
    "發證日期": "86\/05\/29",
    "許可證種類": "製　劑",
    "舊證字號": "02020480",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202171400",
    "中文品名": "依托普塞注射液",
    "英文品名": "ETOPOSIDE INJECTION",
    "適應症": "抗癌症",
    "劑型": "270注射劑",
    "包裝": "小瓶 盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "ETOPOSIDE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "新北市淡水區中正東路二段１７７號",
    "主製造廠": {
        "製造廠名稱": "F020034000  PFIZER (PERTH) PTY LIMITED",
        "製造廠廠址": "15 BRODIE HALL DRIVE TECHNOLOGY PARK, BENTLEY WESTERN AUSTRALIA 6102",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001000",
            "成分名稱": "ETOPOSIDE",
            "含量描述": "20",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ]
}